Viewing Study NCT06452095



Ignite Creation Date: 2024-06-16 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06452095
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-11
First Post: 2024-06-07

Brief Title: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition
Sponsor: University Health Network Toronto
Organization: University Health Network Toronto

Study Overview

Official Title: RECLAIM Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition RECLAIM-HBOT
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RECLAIM - HBOT
Brief Summary: The RECLAIM study platform will be used to explore whether the use of Hyperbaric Oxygen therapy HBOT may be used to improve the symptoms of post covid condition

Hyperbaric oxygen therapy is a well-established medical treatment HBOT promotes healing by delivering a high concentration of oxygen into the body This high level of oxygen has a number of known benefits such as growth of new blood vessels as well as regulating immune and inflammation responses It helps protect the brain and other nervous tissue from inflammation HBOT may also have antiviral effects

Collectively it has the potential to target the underlying mechanisms believed to play a critical role in the development of Long COVID

Many patients with Long COVID complain of fatigue brain fog muscle aches and other symptoms There is evidence to suggest that these symptoms may be a problem with the blood vessels resulting in abnormal delivery of oxygen to tissues Thus our group is investigating whether HBOTs ability to improve the delivery of oxygen to tissues may help these symptoms
Detailed Description: This is a Sub-Protocol to the Core Clinical Study Protocol titled REcovering from COVID19 Lingering symptoms Adaptive Integrative Medicine RECLAIM

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None